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Background: Reactive gliosis had been implicated in injury and recovery patterns associated with hydrocephalus.
Our aim is to determine the efficacy of minocycline, an antibiotic known for its anti-inflammatory properties, to
reduce reactive gliosis and inhibit the development of hydrocephalus.
Results: The ventricular dilatation were evaluated by MRI at 1-week post drugs treated, while GFAP and Iba-1were
detected by RT-PCR, Immunohistochemistry and Western blot. The expression of GFAP and Iba-1 was significantly
higher in hydrocephalic group compared with saline control group (p < 0.05). Minocycline treatment of
hydrocephalic animals reduced the expression of GFAP and Iba-1 significantly (p < 0.05). Likewise, the severity of
ventricular dilatation is lower in minocycline treated hydrocephalic animals compared with the no minocycline
group (p < 0.05).
Conclusion: Minocycline treatment is effective in reducing the gliosis and delaying the development of
hydrocephalus with prospective to be the auxiliary therapeutic method of hydrocephalus.
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Hydrocephalus is a common medical condition charac-
terized by abnormalities in the secretion, circulation and
resorption of cerebrospinal fluid (CSF), resulting in ven-
tricular dilatation. Gliosis and neuroinflammation are
prevalently associated with hydrocephalus, and reactive
astrocytes and microglia have been found throughout
the hydrocephalic brain, and followed by brain tissue fi-
brosis and function deterioration [1-7]. Previous studies
have noted that reactive astrocytosis and microgliosis
are commonly found in hydrocephalus rats with neo-
natal congenital [1,3,4,8] and acquired obstructive [2,6,8]
hydrocephalus, with a perinatal onset followed by up to
5 weeks of postnatal ventriculomegaly. Astrocytosis has
also been reported in juvenile and adult models of
hydrocephalus [9,10].
As a second generation tetracycline-based molecule,
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reproduction in any medium, provided the orastrocytes activation [11-15]. Because it is a highly lipo-
philic compound and can penetrate the brain-blood bar-
rier easily, many studies used it for the treatment of
central nervous system disease, and its role of reducing
the brain injury after intracerebral hemorrhage has been
reported [12,16,17].
We established hydrocephalus rats model by kaolin in-
ducing and treated them with minocycline, then evalu-
ated the ventricle enlargement by MRI. At the same
time, the gene expression of GFAP (glial fibrillary acidic
protein, for astrocytes) and Iba-1 (ionized calcium bind-
ing adaptor molecule, for microglia) were detected to ex-
plore the effectiveness of minocycline in reducing gliosis




Adult male Sprague–Dawley rats (240–260 g) were pur-
chased from Slac Laboratory Animal Co. Ltd. (Shanghai,
CA). Food and water were provided ad libitum. Animals
were housed in a temperature- and humidity-controlled
environment with a 12-h light/dark cycle. The rats wereThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The relative locations of a rat brain used for various
assays in this study. The first part for pathological study the
second for immunohistochemical study; the third for Western
blotting and the fourth for qRT-PCR analysis.
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(n=20) with kaolin injections, and control group (n=10)
with saline injections. Then the model group were ran-
domly subdivided into the untreated hydrocephalic
group (n=9) and the minocycline-treated hydrocephalic
group (n=9) at 2-week post-operation. Experimental pro-
cedures were performed according to the guidelines of
the Animal Experiment Ethics Committee of Xiamen
University.
Surgical induction
All the intervener and evaluator were blinded. The rats
were anaesthetized by intraperitoneal injection of 10%
chloral hydrate (0.4 ml/100 g), and were placed in a
stereotaxic frame. The injection coordinates, which were
measured from the bregma to the lateral cerebral ventri-
cles, were 0.8 mm posterior, 1.6 mm lateral and 3.7 mm
deep. A 30-μl sterile suspension of 3% kaolin (ultrasonic
emulsification about 15 minutes) was injected slowly
into the lateral cerebral ventricles (depth: 3.7 mm) at a
rate of approximately 10 μl/min. The skin incision was
sutured, and the animal was replaced in its cage and was
monitored daily for the duration of the experiment.
Sham control rats underwent the same procedure but
received sterile saline injection instead of kaolin [18].
Due to the small size of the young rats used in this
study (250 g for adults) intravenous injection was not a
practical method of minocycline delivery. Therefore,
intraperitoneal injections were used instead [7,19]. This
type of administration has been shown to provide ad-
equate delivery of minocycline to the brain across the
blood brain barrier as assessed by both serum and CSF
levels [20]. Minocycline treated animals received mino-
cycline HCl (Sigma Chemicals, St. Louis, USA) dissolved
in 5% sucrose at a concentration of 10 mg/ml at a dose
of 45 mg/kg/day for 7 days, beginning at post-injection
day 15 and ending at day 21 with the termination of the
experiment. Injection sites were rotated between the
four abdominal quadrants.
Magnetic resonance imaging and ventricular
measurement
Magnetic resonance imaging (MRI) was performed on
all animals 14 days post-injection. The animals were
anesthetized with chloralic hydras and all scans were
performed on a 7.0-Tesla horizontal-bore small animal
MRI scanner (BrukerBiospec, Billerica, MA, USA) abid-
ing by the protocol described previously. Evan's ratios
[21] and ventricular volumes were measured from the
coronal MRI scans of the saline control and hydroceph-
alic brains.
Ventricular volumes (lateral and 3rd ventricles) were
calculated according to T2 images, starting from the
center of the cerebral aqueduct up to the anterior-mostportion of the lateral ventricles. The volumetric calcula-
tions were semiautomated(by NIH Image)as follows: an
appropriate intensity threshold was first chosen to ex-
clude background tissue and to highlight the bright ven-
tricles. This was followed by careful inspection of each
image, and manual tracing was used to correct any area
of the ventricle, which had been incorrectly deleted, or
to delete nonventricular regions that had been incor-
rectly included. This process resulted in a binary mask
of ventricular pixels, which multiplied by the volume of
each pixel and summed over all slices produced the net
ventricular volume in milliliters. The Evan’s ratio was
taken at the level of the Foramen of Monroe as the max-
imum width of both lateral ventricles divided by the
maximum width of the brain at this level.
Sacrifice and tissue sample collection
On post-treated day 8 following the MRI, each group of
rats were anesthetized with 10% chloral hydrate (0.4 ml/
100 g, i. p.) and perfused with 0.9% saline by left atrial
perfusion. For histological analysis, the brains were
removed from the skull. Each brain was divided into
four parts between optic chiasma and cerebral peduncle
[22,23]. The first and second parts of the brain were
fixed in 10% formalin for 24 h at 4°C and then embed-
ded in paraffin for histological and immunohistochem-
ical studies respectively. And the third and fourth parts
were stored at -80°C for western blot and qRT-PCR re-
spectively (Figure 1).
RT-PCR
Total RNA was extracted by Trizol reagent (Invitrogen,
USA) according to the manufacturer's instructions.
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using commercially available reagents (TaKaRa, Japan)
with the StepOne Real-Time PCR System (ABI, UK).
Sybr Green I was used to detect amplification and β-
actin was used as a normalizing control. Forward and re-
verse primers were as follows (Table 1):
The RT-PCR consisted of two programs. The first one
was complementary cDNA synthesis: one cycle at 50°C
for 30 min and one cycle at 94°C for 2 min. The other
one was second-strand cDNA synthesis and the PCR
consisted of 45 cycles at 94°C for 30s, 58°C for 30s, and
72°C for 20s, followed by a final extension step at 72°C
for 10 min. Calculations were performed by the CP
method. All samples were assayed in triplicates.
Immunohistochemistry
Paraffin-embedded brains of optic chiasma which is of
the lateral ventricle level were sectioned coronally at a
thickness of 5 μm, and were immunohistochemically
stained for detecting the expression of GFAP and Iba-1
with 2-step EliViaion+ kit (Maixin. Bio, CA) according
to the manufacturer's instructions. In brief, after dewax-
ing and rinsing with PBS, for antigen retrieval, sections
were microwave-treated in a steamer for 20 min with
10 mmol citrate buffer (pH 6.0) preheated to 90-100°C,
followed by rinsing again and incubation in 3% H2O2 for
10 min. Tissue sections were then blocked with blocking
serum for 20 min. The tissue sections were incubated
with monoclonal antibody against GFAP (1:1000) and
with polyclonal antibody against Iba-1 (1:200) (abcom
Biotechnology, USA) respectively, overnight at 4°C in a
moist chamber. Then, the slides were incubated for
30 min at 37°C with Elivison+, peroxidase, rabbit (for
GFAP and Iba-1) and subsequently reacted with 3,3-dia-
minobenzidine (DAB) mixed solution (Maixin. Bio, CA)
for 2–3 min as a chromogen substrate. The nucleus was
counterstained by Meyer hematoxylin. Then, the slides
were dehydrated and mounted. Negative controls were
incubated without primary antibodies.
Western blotting
Anesthetized animals were decapitated, and the brain
was promptly removed and dissected on ice. Samples






AIF-1 Forward 5’-GAATTCACCATGAGCCAAAC 30
Reverse 5’-GGATCCTTAGGGCAACTCAG 30in liquid nitrogen, and then transferred and stored in
−80°C until use. Tissue from Sham Control group
(n=10), Hydrocephalic with minocycline group(n=9) and
Hydrocephalic no minocycline group(n=9) was placed in
separate vials containing RIPA buffer(Pierce 89900) with
a protease inhibitor tablet (Roche-Complete Mini 4°C)
and sonicated. After centrifugation at 13,000 rpm for
10 min at 4°C, the supernatant was aliquoted and frozen
with a sample from each animal retained for protein
quantification. Protein quantification was performed
using BCA Protein Assay Kit (Thermo Scientific, Pitts-
burg PA.). Absolute protein content was calculated using
Lowry method [24].
Proteins from the control and hydrocephalic parietal
cortices were obtained at appropriate working concen-
trations by mixed with an equal volume of Laemmli buf-
fer with -mercaptoethanol and heated at 90°C for 5 min,
loaded into each lane, and electrophoresed in a 10%
SDS-polyacrylamide gel in 1×Tris/Glycine/SDS buffer at
150 V for 1.5 h at room temperature. Separated proteins
were electrophoretically transferred to a PVDF mem-
brane using 1×Tris/Glycine buffer for 30 min at 100 V
and 4°C. The membrane was washed in Tris-buffered sa-
line +Tween (TBS-t) and blocked in 5% milk for 1 h at
RT. Primary antibody for GFAP (abcom, Cambridge
US.) and Iba-1(abcom, Cambridge US.) the reference
protein GAPDH(abcom, Cambridge US.) were applied at
a dilution of 1:1,000 for 2 h at RT followed by 3 washes
in TBS-t. Secondary antibody, peroxidase-conjugate
anti-rat IgG, was applied at a dilution of 1:1,000 for 1 h
followed by 3 washes in TBS-t. Finally, ECL reagent was
added to the membrane, and the membrane was
exposed on film. Western blots were quantified by
densitometry readings from the appropriate bands
(GFAP 50 kDa and Iba-1 17 kDa). To accurately quantify
the bands, the relative intensities of GFAP and Iba-1
were divided by the relative intensity of our loading con-
trol GAPDH (37 kDa).
Data analysis
Data were generally expressed as mean ± standard error
(SE) values. Groups of data were compared by a one-
way ANOVA. Two comparisons were made - between
the saline control and hydrocephalic animals; and be-
tween hydrocephalic with minocycline and hydroceph-
alic without minocycline groups. A value of P<0.05 was
considered to be statistically significant.
Results
Behavior, mortality and general changes
Rats were watched and weighed daily. Two rats in the
hydrocephalic group died within 3 days post-operation.
All rats with kaolin injection into the lateral ventricle suc-
cessfully developed moderate to severe hydrocephalus
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alic groups exhibited irritability, increased urine, cough-
ing, hunched back, hind legs weakness and nasal and/or
orbital secretions of blood and clear fluid after 1 day
post-operation. These signs disappeared spontaneously
within a few days. Weight growth of hydrocephalus ani-
mals was significantly slower than that of the sham con-
trol group. Besides, there is no significant difference
between Hydrocephalic with minocycline rats and Hydro-
cephalic no minocycline group.
MRI
Animals with saline injections into the lateral ventricle
did not develop hydrocephalus; however, all rats with
kaolin injections developed hydrocephalus. In these ani-
mals, MRI confirmed ventriculomegaly (P<0.05). The
lateral ventricles enlarged equally, which confirmed that
the obstruction was between spinal and cortical sub-
arachnoid space (in traditional concept it was classified
of communicating hydrocephalus) [25]. Severely hydro-
cephalic brains exhibited dramatic expansion of the lat-
eral ventricles, as well as a parietal cortex that was
substantially thinned and edematous. The third ventricle,
cerebral aqueduct, and fourth ventricle were enlarged as
well, but not to the same degree as the lateral ventricles
(Figure 2). Before drug treatment, the MRI results
showed no difference on the Ventricular volumes and
Evan’s ratio between the two groups. The ventricular
volumes of both the minocycline group and the no min-
ocycline group were enlarged after drug treatment
period. Yet, the Ventricular volumes and Evan’s ratio of
minocycline group is smaller (P<0.05) compared to the
no minocycline group (Table 2).
RT-PCR
RT-PCR (Figure 3) revealed that the mRNA expression
of the GFAP and AIF-1 significantly (P<0.05) elevated in
hydrocephalic brain. Meanwhile, the level evaluation is
more obvious (P<0.05) in hydrocephalic no minocycline
group than that of the minocycline group and it wasFigure 2 Coronal T2-weighted MR images of controls and rats with hyrevealed by correlation analysis that the increase was
positively correlated with the severity of ventricular
dilatation.
Immunohistochemistry
GFAP and Iba-1 immunostaining (Figure 4) revealed
both resting and reactive glial cells in preventricular tis-
sue and parietal cortex. The parietal cortex in saline
control animals contained predominantly resting astro-
cytes and microglial cells, which are both characterized
by a lightly stained cell body and thin processes. In the
hydrocephalic no minocycline group, highly reactive
astrocytes, which had the typical appearance of dark
enlarged cell bodies and thick processes, were found
throughout the cortex. Likewise, densely-packed reactive
microglial cells were also frequently found in preventri-
cular area and cortex of these animals. In the hydro-
cephalic with minocycline group, the typical appearance
of dark enlarged cell bodies was relatively fewer than in
the no minocycline group.
Western blot analysis
GFAP protein and Iba-1 expression increased signifi-
cantly (P<0.01) in the hydrocephalic groups compared to
the saline control group. In hydrocephalic with minocy-
cline group, GFAP protein and Iba-1 expression are
lower than hydrocephalic no minocycline group
(P<0.05). It revealed by correlation analysis that the de-
crease was positively correlated with the severity of ven-
tricular dilatation (Figure 5).
Discussion
In traditional concept, hydrocephalus was divided into
obstructive and communicating. And when the obstruc-
tion occurs between spinal and cortical subarachnoid
space, it was classified as communicating hydrocephalus.
Recently, a consensus on the classification of hydroceph-
alus was reached [26], kaolin deposition in subarachnoid
space is also a resistant elements within the CSFdrocephalus are shown.















(n=10) (n=9) (n=9) (n=9) (n=9)
Ventricular
volumes(mm3)
16±8 49±10 57±12 98±18 140±21
Evan’s ratio 0.29±0.04 0.33±0.03 0.34±0.04 0.42±0.05 0.56±0.09
Body weight(g) 381 311 326 315 349
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municating hydrocephalus.
In the present study, our RT-PCR, Immunohistochem-
istry and Western blot all confirm that minocycline can
reduce the expression of GFAP and Iba-1 in hydroceph-
alic rats. Although it cannot revise the development of
hydrocephalus, minocycline can delay its progress. The
mechanism might operate through inhibition of astro-
gliosis and glial scar formation thereby decreasing the
damage to periventricular white matter. GFAP is an
intermediate filament specifically seen in astrocytes. As
to functions of reactive astrocytes, it has been reported
that reactive astrogliosis and glial scar formation play
crucial roles in regulating CNS inflammation [27]. Glial
scar formation could play a major role in causing the
problem that chronically plague hydrocephalic children.
It has been suggested by many investigators [28] that
GFAP-labeled reactive astrocytes were present in differ-
ent hydrocephalic animal models. Clinically, increased
levels of GFAP protein have been found in the CSF of
patients with normal pressure hydrocephalus, and
patients who developed secondary hydrocephalus due to
subarachnoid hemorrhage [29-31]. At the same time, the
possibility of using GFAP protein levels as a diagnosticFigure 3 Mean ranking score for GFAP(A) and AIF-1(B) expression in b
minocycline group(n=9) and Hydrocephalic no minocycline group(n=
Hydrocephalic no minocycline rats expressed levels increased(P<0.01) of GF
The GFAP and AIF-1 expression of Hydrocephalic with minocycline group atool for hydrocephalus is currently being explored
[32,33].
Astrocytes, in nature, seem to perform a regulatory
function in the processes of microglial differentiation and
activation in response to inflammation, considering their
role in the antigen-presenting process. Extracellular glu-
tamate levels increased and astrocytes are stimulated in
brain injury, thus producing calcium wave propagations
and releasing nucleosides and nucleotides which in turn
enable a stimulation of proliferation of microglia [34-36],
with a wide production of molecules, including cyto-
kines. The cytokines interleukin 1β (IL-1β), interferon-γ
(IFN-γ), and tumor necrosis factor (TNF-α) are import-
ant for microglial activation since they can induce prolif-
eration and functional changes in microglial cells.
However, as they also act upon astrocytes, they can cre-
ate cascade effects contributing to both perpetuation of
inflammation by a vicious circle and affecting neuronal
function. Coupled with microglia, astrocytes also release
trophic factors such as basic fibroblast growth factor,
nerve growth factor (NGF), ciliaryneurotrophic factor,
and S100β, thus promoting neuroplasticity and rebuild-
ing of the nervous system after injury. The release of
trophic factors is possibly mediated by ATP, whichrain tissue for sham Control group(n=10), Hydrocephalic with
9). The result were expressed GFAP/β-actin or Iba-1/β-actin. The
AP protein and AIF-1 when compared with Sham control animals(#).
re lower(P<0.05) than that of no minocycline group(*).
Figure 4 Representive images of GFAP(A) and Iba-1(B) of the preventricular tissue (white matter dorsal to frontal horn of lateral
ventricle).
Figure 5 Proteins were processed for Western blot to assess levels of GFAP and Iba-1(A). Mean ranking score of GFAP(B) and Iba-1(C) in
brain tissue for Sham Control group(n=10), Hydrocephalic with minocycline group(n=9) and Hydrocephalic no minocycline group(n=9) were
analysed. The Hydrocephalic no minocycline group expressed levels significantly(P<0.01) increased of GFAP and Iba-1 protein when compared
with Sham control animals (#). The GFAP and Iba-1 expression of Hydrocephalic with minocycline group are lower(P<0.05) than that of no
minocycline group(*).
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astrocytes and microglia in tissue repair pathways by
stimulating purinergic receptors [37,38].
Microglia are cells within the brain which are activated
in response to injury. Depending upon specific condi-
tions, they can have neurotrophic or neurotoxic actions.
In normal brain, microglia are in a quiescent state; How-
ever in the event of injury, they become highly phago-
cytic and they are involved in clearing debris from the
damaged site. Activated microglia are found associated
with ischemic and hemorrhagic brain injury, including
intracerebral hemorrhage. Activated microglia upregu-
late a variety of surface receptors, including the major
histocompatibility complex (MHC) and complement
receptors [39], and release a wide variety of proinflam-
matory mediators such as cytokines, chemokine, proteo-
lytic enzymes, reactive oxygen species, and complement
protein [40]. Activated microglia are found associated
with ischemic and hemorrhagic brain injury, including
intracerebral hemorrhage. Our previous study also con-
firmed that the degrees of astrocytpsis and microgliosis
are positively related to the development of hydroceph-
alus and indicated a detrimental role of glial cells in
hydrocephalus despite of the protective role of reactive
gliosis [23].
Minocycline, a second generation tetracycline-based
molecule, is a highly lipophilic compound and penetrates
the brain–blood barrier easily [16,41]. Minocycline has
neuroprotective effect such as anti-oxidation, anti-in-
flammatory, anti-apoptosis [42-44], and its protection
role in ischemiare perfusion injury and neuropathic pain
has been reported [45]. An in vitro study showed that
minocycline reduced excitotoxicity in primary neuronal
culture by preventing excitotoxin-induced microglial
proliferation [11]. It also inhibits macrophage/microglia
activation after intracerebral hemorrhage in the rat
[17,46]. Another study suggested that minocycline re-
duce the late histopathological consequences by restor-
ing sAPPα levels [47]. Overall, these data suggested that
minocycline treatment is effective in reducing the gliosis
and the severity of hydrocephalus with prospective to be
the auxiliary therapeutic method of hydrocephalus.
Conclusion
To hydrocephalic patients, surgery can only release
symptoms while etiological treatment intend to be more
promising therapeutic strategy. As multiple factors con-
tribute to the development of hydrocephalus, despite of
the experiment confirmed the effectiveness of minocy-
cline to some degree, its underling mechanism is yet un-
clear and needs further exploration.
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